מרוקן ישראל - עברית - Ministry of Health

מרוקן

taro pharmaceutical industries ltd - macrogols; potassium chloride; sodium bicarbonate; sodium chloride - אבקה להכנת תמיסה - macrogols 315.0 g; potassium chloride 1.1175 g; sodium bicarbonate 4.2840 g; sodium chloride 8.4240 g - mineral salts in combination - mineral salts in combination - bowel cleansing prior to colonoscopy and barium enema x-ray examinations.

מוביפרפ   ישראל - עברית - Ministry of Health

מוביפרפ

padagis israel agencies ltd, israel - ascorbic acid; macrogols; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate anhydrous - אבקה להכנת תמיסה - potassium chloride 1.015 g; sodium ascorbate 5.9 g; macrogols 100 g; sodium chloride 2.691 g; sodium sulfate anhydrous 7.5 g; ascorbic acid 4.7 g - electrolytes in combination with other drugs - electrolytes in combination with other drugs - for bowel cleansing prior to any clinical procedures requiring a clean bowel e.g. bowel endoscopy or radiology.

אונגלייזה 5 מג ישראל - עברית - Ministry of Health

אונגלייזה 5 מג

astrazeneca (israel) ltd - saxagliptin as hydrochloride - טבליות מצופות פילם - saxagliptin as hydrochloride 5 mg - saxagliptin - saxagliptin - monotherapy: onglyza is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.onglyza should not be used in patients with esrdcombination therapy: add-on combination: onglyza is indicated in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin, a thiazolidinedione (tzd), or a sulfonylurea (su), when the single agent alone, with diet and exercise, does not provide adequate glycemic control.initial combination: onglyza is indicated for use as initial combination therapy with metformin, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes mellitus when dual saxagliptin and metformin therapy is appropriate.onglyza should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. in combination with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

אונגלייזה 2.5 מג ישראל - עברית - Ministry of Health

אונגלייזה 2.5 מג

astrazeneca (israel) ltd - saxagliptin as hydrochloride - טבליות מצופות פילם - saxagliptin as hydrochloride 2.5 mg - saxagliptin - saxagliptin - monotherapy: onglyza is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.onglyza should not be used in patients with esrdcombination therapy: add-on combination: onglyza is indicated in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin, a thiazolidinedione (tzd), or a sulfonylurea (su), when the single agent alone, with diet and exercise, does not provide adequate glycemic control.initial combination: onglyza is indicated for use as initial combination therapy with metformin, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes mellitus when dual saxagliptin and metformin therapy is appropriate.onglyza should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. in combination with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

אונגלייזה 2.5 מג ישראל - עברית - Ministry of Health

אונגלייזה 2.5 מג

astrazeneca (israel) ltd - saxagliptin as hydrochloride - טבליות מצופות פילם - saxagliptin as hydrochloride 2.5 mg - saxagliptin

אונגלייזה 5 מג ישראל - עברית - Ministry of Health

אונגלייזה 5 מג

astrazeneca (israel) ltd - saxagliptin as hydrochloride - טבליות מצופות פילם - saxagliptin as hydrochloride 5 mg - saxagliptin

סיטאר 100 ישראל - עברית - Ministry of Health

סיטאר 100

unipharm trading ltd, israel - sitagliptin as hydrochloride - טבליות מצופות פילם - sitagliptin as hydrochloride 100 mg - sitagliptin

סיטאר 25 ישראל - עברית - Ministry of Health

סיטאר 25

unipharm trading ltd, israel - sitagliptin as hydrochloride - טבליות מצופות פילם - sitagliptin as hydrochloride 25 mg - sitagliptin

סיטאר 50 ישראל - עברית - Ministry of Health

סיטאר 50

unipharm trading ltd, israel - sitagliptin as hydrochloride - טבליות מצופות פילם - sitagliptin as hydrochloride 50 mg - sitagliptin

דיפרוספאן זריקה ישראל - עברית - Ministry of Health

דיפרוספאן זריקה

organon pharma israel ltd., israel - betamethasone as dipropionate; betamethasone sodium phosphate - תרחיף להזרקה - betamethasone sodium phosphate 2 mg/ml; betamethasone as dipropionate 5 mg/ml - betamethasone - betamethasone - produces anti-inflammatory, anti rheumatic and anti-allergic action and is indicated for systemic and local therapy of acute and chronic corticosteroid-responsive disorders.